RFX5 promotes the progression of hepatocellular carcinoma through transcriptional activation of KDM4ADongbo Chen, Hongsong Chen, Xueyan Wang et al.|Scientific Reports|2020Cited by 34
Genome-scale CRISPR activation screening identifies a role of ELAVL2-CDKN1A axis in paclitaxel resistance in esophageal squamous cell carcinoma.Wensi Zhao, Ke‐Neng Chen, Wanpu Yan et al.|PubMed|2019Cited by 31
Regulatory factor X5 promotes hepatocellular carcinoma progression by transactivating tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta and suppressing apoptosisDongbo Chen, Hongsong Chen, Yangjing Zhao et al.|Chinese Medical Journal|2019Cited by 28
Dominant neoantigen verification in hepatocellular carcinoma by a single-plasmid system coexpressing patient HLA and antigenPu Chen, Hongsong Chen, Dongbo Chen et al.|Journal for ImmunoTherapy of Cancer|2023Cited by 13
A Novel Nomogram to Predict Prolonged Survival After Hepatectomy in Repeat Recurrent Hepatocellular CarcinomaQiongxuan Fang, Hongsong Chen, Ruifeng Yang et al.|Frontiers in Oncology|2021Cited by 9